What Borvo Medical does

Borvo Medical is a privately held, early-stage neurosurgical medical device company headquartered in Mountain View, California. The company designs, develops, and commercializes minimally invasive devices for subdural hematoma (SDH) drainage, with its flagship product, the Borvo EVAC™ (Endoport Vacuum Assisted Collection) system, receiving U.S. FDA 510(k) clearance in October 2024. The EVAC platform comprises two patent-pending design variants — EVAC Ergo™ (streamlined ergonomic shape) and EVAC Classic™ (traditional form factor) — both fabricated from state-of-the-art 3D-printed non-ferromagnetic titanium. Differentiating technical features include a larger, tapered lumen designed to reduce clogging during use, MR-compatibility that broadens post-operative imaging and monitoring options, and reduced CT artifacts versus incumbent stainless-steel devices such as SEPS, plus the ability to perform bilateral SDH drainage in a single surgical session.

Borvo generates revenue through direct sales of its EVAC hardware to hospitals and medical centers performing neurosurgical and neurointerventional procedures, targeting chronic SDH drainage — increasingly in combination with middle meningeal artery (MMA) embolization. The company's go-to-market blends enterprise field sales with conference-driven awareness (Society of Neurointerventional Surgery Annual Meeting, World Federation of Interventional and Therapeutic Neuroradiology Congress) and physician-targeted press releases. Borvo is a portfolio company of NeuroTechnology Investors (NTI), a physician investment group established in 2016 that supplies both capital and clinical expertise; the Jacobs Institute is also listed as a partner. The company is led by Chairman/CEO Martin Dieck (30 years founding and exiting brain-device companies, NTI founding director) and COO Soren Thompson (eight years of medical-device R&D, operations, and commercialization; Columbia MBA in Healthcare and Pharmaceutical Management).

As of mid-2025, Borvo had validated the EVAC system across five medical centers (Atlantic Health System, JFK University Medical Center, Mount Sinai Health System, St. Lukes Health System, and University of Virginia) with a reported 100% success rate in the initial 25 patients, and announced immediate plans to scale commercial efforts across the United States. Headcount is stated at 1–10 employees; no revenue, pricing, or funding round details are publicly disclosed.

Name

Borvo Medical

Legal name

Borvo Medical, Inc.

Website

https://borvomedical.com

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

1–10 employees

Short description

Borvo Medical is a private neurosurgical medtech company developing FDA-cleared, 3D-printed titanium minimally invasive devices (the EVAC system) for subdural hematoma drainage, sold directly to US hospitals performing neurointerventional procedures.

Ownership category

akta.pro rank

Product category

Neurosurgical Medical Devices

NAICS

Medical Equipment and Supplies Manufacturing (3391)

SIC

Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Thrombectomy, Embolic Protection & Stroke Intervention Devices (HLAHAFAJ)

Keywords

• Neurosurgical medical devices
• Subdural hematoma drainage
• Minimally invasive neurosurgery
• 3D printed titanium implants
• Endoport vacuum systems

Headquarters

HQ city

Mountain View

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Others

Revenue model

1. EVAC System Sales: Sale of FDA-cleared Borvo EVAC (Endoport Vacuum Assisted Collection) surgical device system for subdural hematoma drainage procedures. The system includes specialized surgical instruments fabricated with 3D printed titanium.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels3 records

Core offering

Borvo Medical develops and sells the FDA-cleared Borvo EVAC™ (Endoport Vacuum Assisted Collection) system for minimally invasive subdural hematoma (SDH) drainage. The system comprises two patent-pending designs — EVAC Ergo™ (ergonomic shape) and EVAC Classic™ (traditional form) — fabricated from 3D printed non-ferromagnetic titanium and sold directly to hospitals and neurosurgeons.

Product overview

Borvo Medical offers a single unified product line centered on the Borvo EVAC™ (Endoport Vacuum Assisted Collection) system for subdural hematoma drainage. The system comprises two distinct design variants—EVAC Ergo™ (with a streamlined ergonomic shape) and EVAC Classic™ (with a traditional form factor)—both fabricated using state-of-the-art 3D printed non-ferromagnetic titanium. The products share core technology including patent-pending designs with a larger lumen, MRI compatibility, and reduced CT artifacts, enabling improved intraoperative and follow-up imaging during neurosurgical procedures.

Differentiator

Problem solved

Functional benefit

Brands

• EVAC Ergo™: Streamlined, ergonomically designed shape for subdural hematoma drainage.
• EVAC Classic™

Products and services

• Borvo EVAC™ (Endoport Vacuum Assisted Collection) System FDA-cleared surgical device system for subdural hematoma (SDH) drainage, comprising two patent-pending designs (EVAC Ergo™ and EVAC Classic™) fabricated from 3D printed non-ferromagnetic titanium. Sold directly to hospitals and neurosurgeons for minimally invasive brain surgery with MR compatibility, reduced CT artifacts, and a larger tapered lumen to reduce clogging.
• EVAC Ergo™ Streamlined, ergonomically designed variant of the Borvo EVAC system, shaped for improved ease of use during subdural hematoma drainage procedures. Targeted at neurointerventional surgeons and neurosurgeons.
• EVAC Classic™ Traditionally designed variant of the Borvo EVAC system, modeled in a traditional form factor for subdural hematoma drainage procedures. Targeted at neurointerventional surgeons and neurosurgeons who prefer a familiar surgical technique.

Quantifiable outcome

• 100% success rate in 25 initial patients across 5 medical centers
• +2 more outcomes

Named customers5 records

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• Jacobs InstituteminorStrategic or Co-development PartnerJacobs Institute is listed as a partner on the Borvo Medical team page. The Jacobs Institute is associated with medical device innovation in neurology.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Stryker Neurovascular: Stryker's Neurovascular division (built on its acquisition of Surpass and earlier neurovascular franchises) is a leading provider of devices for hemorrhagic and ischemic stroke treatment, including access devices and stent retrievers. Comparable as a large incumbent in the neurovascular space where Borvo EVAC is used in adjacent procedures.
• Penumbra: Penumbra is a publicly-traded neurovascular device company with a broad portfolio including aspiration catheters for stroke and other neurovascular interventions. It is comparable as a neurovascular incumbent whose products are often used in conjunction with or adjacent to MMA embolization procedures for SDH treatment.
• Inari Medical: Inari Medical (acquired by Stryker) develops mechanical thrombectomy devices for venous thromboembolism with growing neurovascular adjacency. Comparable as a venture-stage device company that scaled a procedural catheter platform into a large incumbent acquisition, illustrating the exit trajectory available to neurovascular specialists like Borvo.
• Medtronic Neurovascular: Medtronic's Neurovascular business offers a broad portfolio including flow diversion, embolization, and thrombectomy products used in the same neurovascular procedure suite as SDH drainage. Comparable as the largest incumbent serving the same neurosurgery hospital customers.
• Integra LifeSciences: Integra LifeSciences offers a broad portfolio of neurosurgical products including dural repair, tissue ablation, and intracranial pressure monitoring devices. Comparable as a broad incumbent neurosurgery device supplier that competes for hospital neurosurgery shelf space and procurement budgets.

Emerging players

• Imperative Care: Imperative Care is a venture-backed neurovascular company developing access and aspiration technologies for ischemic stroke, with growing presence in adjacent neurovascular procedures. Comparable as an emerging neurovascular player targeting the same hospital neurosurgery departments.
• MicroPort NeuroTech: MicroPort NeuroTech is the neurovascular subsidiary of MicroPort Scientific developing flow diverter and embolization products for neurovascular disorders. Comparable as an emerging neurovascular device company competing in the same stroke/SDH procedure ecosystem.
• Rapid Medical: Rapid Medical develops neurovascular devices including stent retrievers and access catheters for ischemic and hemorrhagic stroke treatment. Comparable as an emerging innovator focused on neurointerventional procedures that overlap with the MMA embolization/SDH workflow.

Direct peers

• Nico Corporation: Nico Corporation manufactures minimally invasive neurosurgical devices including the BrainPath and Myriad systems for tumor and hemorrhage access and resection. Comparable as a direct peer focused on specialized, minimally invasive neurosurgical tools sold to the same neurosurgery customer base.

Regional players

• Mizuho Medical / Mizuho America: Mizuho is a Japanese-headquartered manufacturer of surgical instruments including neurosurgical micro-instrumentation used in cranial procedures. Comparable as a supplier of specialty surgical tools to the same neurosurgery specialty channels.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Borvo Medical